QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) plans as
previously announced to release its report on results for the first
quarter 2019 on Monday, May 6 at approximately 22:05 Central
European Time (CET) / 16:05 Eastern Standard Time (EDT). A
conference call is planned for Tuesday, May 7 at 15:00 CET / 9:00
EDT hosted by Peer M. Schatz, Chief Executive Officer, and Roland
Sackers, Chief Financial Officer.
Conference Call and Webcast Details
The conference call will
begin at 15:00 CET / 9:00 EDT on Tuesday May 7, 2019.
Interested parties may listen to the call by
dialing:
+1 929 477 0448 (U.S.), +44 (0)330 336 9125 (UK),
+49 (0)69 2222 25574 (Germany).
To avoid waiting time, please join
the event conference 5-10 minutes prior to the start time.
Quoting
the following Conference ID: 9120987 to the answering operator.
The webcast will be accessible at:
https://globalmeet.webcasts.com/starthere.jsp?ei=1236909&tp_key=fb3cd2e147
A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1236909&tp_key=fb3cd2e147
Contact: IR@qiagen.com
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global
provider of Sample to Insight solutions that enable customers to gain
valuable molecular insights from samples containing the building blocks
of life. Our sample technologies isolate and process DNA, RNA and
proteins from blood, tissue and other materials. Assay technologies make
these biomolecules visible and ready for analysis. Bioinformatics
software and knowledge bases interpret data to report relevant,
actionable insights. Automation solutions tie these together in seamless
and cost-effective workflows. QIAGEN provides solutions to more than
500,000 customers around the world in Molecular Diagnostics (human
healthcare), Applied Testing (primarily forensics), Pharma (pharma and
biotech companies) and Academia (life sciences research).
As of
December 31, 2018, QIAGEN employed approximately 5,000 people in over 35
locations worldwide. Further information can be found at http://www.qiagen.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190415005386/en/